This conference, Monitoring & Reducing Medication Errors: High Risk Medicines & Patient Groups, is an on-line event dedicated to reducing medication errors and harm in hospitals. With the aim of the WHO Medicines Without Harm Program to reduce serious, preventable drug-related harm by 50% in the next five years, the focus of the conference is on prescribing high-risk drugs and high-risk patient populations. The purpose is to bring together physicians, managers, drug safety officers and lead to an understanding of current developments in the country, as well as to discuss and discuss the key issues and areas they face in improving and monitoring drug safety, and reducing error and harm. from taking medications in hospitals.

The conference will also address the issue of reducing medication errors in high-risk patient groups such as the elderly, as revealed by the recent HSIB study. Academic studies have shown that more than 200 million errors in medication occur in the elderly or in the presence of comorbidities and polypharmacy. With the average age of patients admitted to the hospital increasing, and operative and clinical pressures within acute hospital care, additional factors may lead to medication errors not identified in older patient groups. The complexity of prescription medications and the risk of harm to the patient if treatment errors occur is heightened by the spectrum of comorbidities and medications taken by the elderly.

This conference provides a platform for exhibitors to showcase their products and services to a wide range of professionals in the field of medication safety. It is an opportunity to network and share best practices with experts in the field, and to learn about the latest developments in monitoring and reducing medication errors.